Harpoon Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HARP and other ETFs, options, and stocks.

About HARP

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. 

CEO
Julia Marie Eastland
CEOJulia Marie Eastland
Employees
99
Employees99
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2015
Founded2015
Employees
99
Employees99

HARP Key Statistics

Market cap
29.07M
Market cap29.07M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
305.13K
Average volume305.13K
High today
$0.9579
High today$0.9579
Low today
$0.825
Low today$0.825
Open price
$0.9304
Open price$0.9304
Volume
255.87K
Volume255.87K
52 Week high
$8.63
52 Week high$8.63
52 Week low
$0.825
52 Week low$0.825

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

HARP Earnings

-$0.66
-$0.44
-$0.22
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.